Efficiency and Safety Study of Pegylated Somatropin to Treat Growth Hormone Deficiency Children

PHASE2CompletedINTERVENTIONAL
Enrollment

101

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

January 31, 2007

Study Completion Date

February 28, 2007

Conditions
Growth Hormone Deficiency
Interventions
DRUG

pegylated Somatropin

0.1 mg/kg/wk once a week for 25 weeks

DRUG

pegylated Somatropin

0.2 mg/kg/wk once a week for 25 weeks

DRUG

Jintropin AQ

0.25 mg/kg/wk, once a day for 25 weeks

All Listed Sponsors
collaborator

Huazhong University of Science and Technology

OTHER

collaborator

First Affiliated Hospital, Sun Yat-Sen University

OTHER

collaborator

Capital Medical University

OTHER

collaborator

Children's Hospital of Fudan University

OTHER

lead

Changchun GeneScience Pharmaceutical Co., Ltd.

INDUSTRY

NCT01342146 - Efficiency and Safety Study of Pegylated Somatropin to Treat Growth Hormone Deficiency Children | Biotech Hunter | Biotech Hunter